QR Kodea

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

ObjectiveThe approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19 pandemic. The aims of our study were to assess and...

Deskribapen osoa

Gorde:
Egile Nagusiak: Zoltán Kiss, Gabriella Gálffy, Veronika Müller, Judit Moldvay, Veronika Sárosi, Zsolt Pápai-Székely, Edit Csada, Anna Kerpel-Fronius, Zsolt Király, Zoltán Szász, Gábor Hódi, Zoltán Polányi, Krisztina Kovács, Eugenia Karamousouli, Kata Knollmajer, Tamás G. Szabó, Andrea Berta, Zoltán Vokó, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, Lilla Tamási, Krisztina Bogos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2023-10-01
Saila:Frontiers in Oncology
Gaiak:
lung cancer
long-term survival
mortality
Hungary
NSCLC
adenocarcinoma lung
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fonc.2023.1207295/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak